GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 169   

Articles published

GSK 1,392.00
price chart
Something Strange Is Going On At GlaxoSmithKline plc�
As part of a drive to rebuild its image after the Chinese bribery scandal, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) announced sweeping changes to the company's employee compensation plan. In an attempt to prevent employees from bribing their way to ...
Why Shire PLC Has Beaten AstraZeneca plc And GlaxoSmithKline plc In 2014
If you invest in pharmaceuticals, Shire (LSE: SHP) is the one you should have bought this year. It's up 60% in the past 12 months to 4,395p, easily beating the FTSE 100's big two - AstraZeneca (LSE: AZN) (NYSE: AZN.
GlaxoSmithKline plc Earns "Neutral" Rating from JPMorgan Chase ...  Ticker Report
Company Rating by First Call: Glaxosmithkline Plc , Progressive Corp  Markets Insider
Related articles »  
GlaxoSmithKline plc Stock Rating Reaffirmed by BNP Paribas (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �underperform� rating restated by BNP Paribas in a research note issued on Wednesday.
GlaxoSmithKline plc Rating Reiterated by BNP Paribas (GSK)  The Legacy
Related articles »  
GlaxoSmithKline Ebola Vaccine Found Safe in Early Tests
GlaxoSmithKline Plc (GSK)'s Ebola vaccine produced responses from the immune system and didn't raise safety concerns in a study with 20 healthy adults, completing an initial step toward making it widely available.
Major Ebola Breakthrough As GlaxoSmithKline (GSK) Reports Promising ...  Bidness ETC
Related articles »  
If I Could Buy Just One Stock For Christmas, It'd Be GlaxoSmithKline plc
It has to be said, I've never been one to crave the �next big gadget�, or to follow the crowd when it comes to following particular trends.
Related articles »  
Which Company Suits Your Portfolio: AstraZeneca plc Or GlaxoSmithKline plc ?
Pharmaceutical companies make great investments due to their defensive nature and reliable dividend payouts. The FTSE 100′s two pharma giants, AstraZeneca (LSE:AZN) (NYSE: AZN.
Glaxo Is Said Near Announcing Reorganization, Job Cuts  Bloomberg
Related articles »  
Could You Double Your Money With GlaxoSmithKline plc?
GSK's share price rise represents a compound annual growth rate (CAGR) of 3.3%. Earnings per share (EPS) have increased at a CAGR of just 1.4%, with the remainder of the share price rise coming from an increase in the price-to-earnings (P/E) ratio.
Related articles »  
3 Stock Stars Yielding Around 5% In 2015: GlaxoSmithKline plc, Legal ...
Backed up by an aggressive acquisition policy and emphasis on developing its brand in emerging markets, Legal & General (LSE: LGEN) (NASDAQOTH: LGGNY.
Related articles »  
GlaxoSmithKline plc's Underperform Rating Reaffirmed at BNP Paribas (LON:GSK)
GlaxoSmithKline plc logo BNP Paribas reissued their underperform rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report released on Wednesday morning.
Related articles »  
GlaxoSmithKline plc Receives Average Rating of �Hold� from Analysts (NYSE ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) has earned an average rating of �Hold� from the twenty-four ratings firms that are covering the stock, Stock Ratings Network.
Related articles »